Answers are grounded in this paper and cite their sources.
Randomized double-blind crossover trial finds no significant increase in adverse reactions between influenza vaccine and placebo in older adults, suggesting vaccine safety fears are unfounded.
Concern about side effects constitutes a major deterrent to patient compliance with influenza vaccination, yet there is a paucity of data about the occurrence of adverse reactions in the population targeted for immunization. We conducted a randomized, double-blind, crossover trial to compare the frequency of adverse reactions following administration of 1988-1989 trivalent split-antigen influenza vaccine and saline placebo. Outpatient veterans 65 years of age or over (n = 336) were recruited by mail and were randomly assigned to receive vaccine followed 2 weeks later by placebo injection or placebo followed 2 weeks later by vaccine. There was no significant difference between influenza vaccine and placebo with respect ot the proportion of subjects reporting disability or systemic symptoms.
No takes yet. Share an insight, caveat, or question.
Karen L. Margolis (1990) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: